Rabbit Leptin
Referencia MBS692825-0,1mg
embalaje : 0.1mg
Marca : MyBiosource
Leptin (LEP) Rabbit Recombinant Protein
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS692825MBS692825 is a recombinant protein targeting LEP. Also known as Rabbit Leptin. Host: E coli. More details
Product Overview
Online Datasheet in PDFProduct Name
Leptin, Recombinant Protein
Full Product Name
Rabbit Leptin
Product Gene Name
LEP recombinant protein
Product Synonym Names
Lep; ob; obese
Sequence
AVPMRKVQDD TKTLIKTIVT RISDISHTQS VSSRQRVVGL DFIPGLHPNL SLSTMDQTLA IYQQILASLP SRNVIQIAND LENLRDLLHL LASSKSCPLP RASGLETLEG LGGVLEASLY STEVVALSRL QGFLQAMLQQ LDLGPGC
Host
E coli
Form/Format
lyophilized, 0.4% NaHCO3, pH 8-9
Purity/Purification
> 97.0% as determined by Gel filtration and SDS-PAGE gel.
Molecular Weight
18,233 Da
Species
Rabbit
Species Reactivity/Cross reactivity
Rabbit
Endotoxin level
<0.1 ng/Ug of protein (<1EU/Ug)
Biological Activity
Recombinant rabbit leptin is fully biologically active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor.
Reconstitution
It is recommended to reconstitute the lyophilized recombinant rabbit leptin in sterile 0.4% NaHCO3 adjusted, not less than 100Ug/ml, which can then be further diluted to other aqueous solutions.
Product Categories/Family for LEP recombinant protein
Cytokines & Growth Factors
ISO Certification
Manufactured in an ISO 9001:2008 Certified Laboratory.
Other Notes
Small volumes of LEP recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for LEP. It may not necessarily be applicable to this product.
NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI Related Accession #
UniProt Primary Accession #
GenBank Nucleotide #
NCBI Official Full Name
leptin
NCBI Official Symbol
LEP
NCBI Official Synonym Symbols
OB
UniProt Protein Name
Leptin
UniProt Synonym Protein Names
Obesity factor
Protein Family
Ethylene-responsive transcription factor
UniProt Gene Name
OB
NCBI Protein Information
leptin
UniProt Comments for LEP
Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic for endothelial cell and affects innate and adaptive immunity. In the arcuate nucleus of the hypothalamus, activates by depolarization POMC neurons inducing FOS and SOCS3 expression to release anorexigenic peptides and inhibits by hyperpolarization NPY neurons inducing SOCS3 with a consequent reduction on release of orexigenic peptides. In addition to its known satiety inducing effect, has a modulatory role in nutrient absorption. In the intestine, reduces glucose absorption by enterocytes by activating PKC and leading to a sequential activation of p38, PI3K and ERK signaling pathways which exerts an inhibitory effect on glucose absorption. Acts as a growth factor on certain tissues, through the activation of different signaling pathways increases expression of genes involved in cell cycle regulation such as CCND1, via JAK2-STAT3 pathway, or VEGFA, via MAPK1/3 and PI3K-AKT1 pathways. May also play an apoptotic role via JAK2-STAT3 pathway and up-regulation of BIRC5 expression. Pro-angiogenic, has mitogenic activity on vascular endothelial cells and plays a role in matrix remodeling by regulating the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). In innate immunity, modulates the activity and function of neutrophils by increasing chemotaxis and the secretion of oxygen radicals. Increases phagocytosis by macrophages and enhances secretion of pro-inflammatory mediators. Increases cytotoxic ability of NK cells. Plays a pro-inflammatory role, in synergy with IL1B, by inducing NOS2 wich promotes the production of IL6, IL8 and Prostaglandin E2, through a signaling pathway that involves JAK2, PI3K, MAP2K1/MEK1 and MAPK14/p38. In adaptive immunity, promotes the switch of memory T-cells towards T helper-1 cell immune responses. Increases CD4+CD25- T-cell proliferation and reduces autophagy during TCR (T-cell receptor) stimulation, through MTOR signaling pathway activation and BCL2 up-regulation.
Show more Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with LEP recombinant protein
| Reference Product | PubMed Publications |
|---|---|
| ADIPOQ recombinant protein | >55 publications with LEP and ADIPOQ |
| STAT3 recombinant protein | >22 publications with LEP and STAT3 |
| INS recombinant protein | >18 publications with LEP and INS |
| IL6 recombinant protein | >13 publications with LEP and IL6 |
| PTPN1 recombinant protein | >2 publications with LEP and PTPN1 |
Pathways associated with LEP recombinant protein
| Products by Pathway | Pathway Diagram |
|---|---|
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Jak-STAT Signaling Pathway antibodies | Jak-STAT Signaling Pathway Diagram |
| Jak-STAT Signaling Pathway antibodies | Jak-STAT Signaling Pathway Diagram |
| Neuroactive Ligand-receptor Interaction Pathway antibodies | Neuroactive Ligand-receptor Interaction Pathway Diagram |
| Neuroactive Ligand-receptor Interaction Pathway antibodies | Neuroactive Ligand-receptor Interaction Pathway Diagram |
Diseases associated with LEP recombinant protein
| Disease Name | Pubmed Publications |
|---|---|
| Obesity Antibodies | >427 publications with LEP and Obesity |
| Pain Antibodies | >208 publications with LEP and Pain |
| Insulin Resistance Antibodies | >133 publications with LEP and Insulin Resistance |
| Hyperinsulinism Antibodies | >91 publications with LEP and Hyperinsulinism |
| Weight Gain Antibodies | >74 publications with LEP and Weight Gain |
| Weight Loss Antibodies | >71 publications with LEP and Weight Loss |
| Inflammation Antibodies | >66 publications with LEP and Inflammation |
| Fatty Liver Antibodies | >49 publications with LEP and Fatty Liver |
| Liver Diseases Antibodies | >48 publications with LEP and Liver Diseases |
| Hyperglycemia Antibodies | >47 publications with LEP and Hyperglycemia |


